Jaume Pahisa

ORCID: 0000-0003-0262-8320 · 3 papers in corpus
2022
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12010226

(1) OBJECTIVE: To assess the performance of CA125, HE4, ROMA index and CPH-I index to preoperatively identify epithelial ovarian cancer (EOC) or metastatic cancer in the ovary (MCO). (2) METHODS: single center retrospective study, including…

article 2015
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.12698

INTRODUCTION: Our objective was to compare the feasibility and safety of surgical procedures to treat gynecological pathologies with intestinal involvement performed by skilled gynecological surgeons and by a multidisciplinary team of gynec…

article 2011
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine ·doi:10.1007/s13277-011-0204-3

The aim of this study is to evaluate a new tumour marker, HE4, in comparison with CA 125 and the Risk of Ovarian Malignancy Algorithm (ROMA) in healthy women and in patients with benign and malignant gynaecological diseases. CA 125 and HE4 …